Regeneron Pharmaceuticals (REGN)
Operating Cash Flow Growth
-49.80%
Quarterly · Period ending:
REGN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-49.80%period ending
Latest reported-49.80%period ending
REGN Quarterly Cash from Operations YoY % (-40.74% → -49.80%)
Year-over-year change
High-resolution chart · PNG
REGN operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -180.0239% | |
| 49.376% | |
| -153.8571% | |
| 45.4026% | |
| 28.7447% | |
| -97.4643% | |
| 222.807% | |
| -283.3333% | |
| -4.4444% | |
| -100% | |
| -283.871% | |
| 347.0588% | |
| -9.7561% | |
| -23.5294% | |
| 3,200% | |
| 75.7143% | |
| 30.5085% | |
| 53.4247% | |
| -104.7619% | |
| 38.0531% | |
| -145.8333% | |
| -10.6061% | |
| 118.4211% | |
| -91.5254% | |
| -141.3793% | |
| 26.6667% | |
| -26.6667% | |
| 1.6667% | |
| 174.359% | |
| -23.2877% | |
| -50% | |
| -57.8947% | |
| -85.7143% | |
| -128.125% | |
| -328.5714% | |
| -40.7407% |